Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc.

PTHS • AMEX

Pelthos Therapeutics Inc. is a biological products, (no disgnostic substances) company trading on AMEX, led by CEO Scott Plesha, with a market cap of $75.5M.

CEOScott Plesha
Market Cap$75.5M
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Employees11.0
Websitechanneltherapeutics.com

Next Earnings

Upcoming earnings announcement for Pelthos Therapeutics Inc.

Date
Saturday, May 9, 2026 (in a month)
Timing
Before Market Open (5:11 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$3.66
Revenue Estimate
$10.2M

Earnings History

Past 3 earnings reports for Pelthos Therapeutics Inc.

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Mar 19, 2026Q4 2025
-$6.87Est: -$4.09
-68.0%
$9.4MEst: $9.1M
+3.5%SEC10-K
Nov 13, 2025Q3 2025
-$5.30Est: -$0.67
-691.0%
$7.4MEst: $6.9M
+7.7%SEC10-Q
Aug 13, 2025Q2 2025
-$5.38Est: -$6.26
+14.1%
-
—SEC10-Q
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Pelthos Therapeutics Inc. (PTHS) Q1 2026 Earnings - Capbase